India Smart Factory Retrofit Economics (Brownfield Focus) Market, By Retrofit Type (Automation Retrofit, Digitalization & Connectivity Retrofit, Energy Efficiency Retrofit, Predictive Maintenance Implementation, Robotics & Cobotics Integration, Food & Beverage Processing); By Technology (Industrial IoT (IIoT), AI & Advanced Analytics, Manufacturing Execution Systems (MES), SCADA & PLC Upgrades, Cloud & Edge Computing); By Investment Objective (Productivity Improvement, Energy Cost Reduction, Quality Improvement, Compliance & Safety); By Industry Vertical (Automotive & Auto Components, Electronics & Electricals, Pharmaceuticals, Food & Beverage, Chemicals, Metals & Heavy Engineering); By Trend Analysis, Competitive Landscape & Forecast, 2021-2032
The India Smart Factory Retrofit Economics (Brownfield Focus) Market will show substantial growth between 2026 and 2032 because more businesses are adopting Industry 4.0 technologies and manufacturers need to upgrade their current production facilities. Indian manufacturers now invest more in affordable brownfield retrofitting solutions to improve their operational efficiency which helps them compete with rising market competition and increasing labor costs and product quality standards. The transition to digital manufacturing combined with automation and energy efficiency improvements creates a need for retrofit solutions that enable complete factory upgrades through existing equipment enhancements.
- Manufacturing
- Feb 2026
- Pages 150
- Report Format: pdf
- Report Price $2500 USD
Thailand EV Manufacturing Supply Chain Market, By Battery Type (Lithium-Ion, Nickel-Metal Hydride, Solid-State); By Vehicle Type (Battery Electric Vehicles, Plug-in Hybrid Electric Vehicles, Hybrid Electric Vehicles); By Component (Battery Cells & Packs, Electric Motors, Power Electronics, Charging Systems & Infrastructure, Thermal Management Systems); By Supply Chain Stage (Raw Material Suppliers, Battery Manufacturers, EV OEMs, Tier-1 & Tier-2 Component Suppliers, Aftermarket & Recycling); By End-User Industry (Passenger Cars, Commercial Vehicles, Two-Wheelers, Buses & Public Transport); By Trend Analysis, Competitive Landscape & Forecast, 2026-2032
The Thailand EV Manufacturing Supply Chain Market is expected to experience substantial growth between 2026 and 2032 due to the country’s increasing adoption of electric vehicles, government incentives for EV manufacturing, and rising investment in battery production and EV component facilities. The demand for EVs is growing because of Thailand’s push toward sustainable transportation, expansion of charging infrastructure, and participation of global EV OEMs establishing manufacturing hubs in the country.
- Manufacturing
- Feb 2026
- Pages 150
- Report Format: pdf
- Report Price $2500 USD
India Pharmaceutical Contract Manufacturing Market, By Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Packaging & Labeling Services, Research & Development (R&D) Services, Drug Development & Manufacturing Services (CDMO)); By Product Type (Branded Drugs, Generic Drugs, Over-the-Counter (OTC) Drugs, Biologics & Biosimilars, Vaccines); By Dosage Form (Tablets, Capsules, Injectables, Syrups & Suspensions, Topical Formulations, Inhalers); By Therapeutic Area (Oncology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Diseases, Diabetes, Others); By End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes); By Trend Analysis, Competitive Landscape & Forecast, 2021-2032
The India Pharmaceutical Contract Manufacturing Market will grow between 2026 and 2032 because of the fast expansion occurring in both the pharmaceutical and biotechnology industries together with the increasing worldwide demand for affordable drug production services. The establishment of contract manufacturing facilities throughout India is being driven by two factors which include the increasing trend of global pharmaceutical companies to outsource their operations and the growing domestic requirement for generic medications and biologic products.
- Manufacturing
- Feb 2026
- Pages 150
- Report Format: pdf
- Report Price $2500 USD
China Pharmaceutical Contract Manufacturing Market, By Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Packaging & Labeling Services, Research & Development (R&D) Services, Drug Development & Manufacturing Services (CDMO)); By Product Type (Branded Drugs, Generic Drugs, Over-the-Counter (OTC) Drugs, Biologics & Biosimilars, Vaccines); By Dosage Form (Tablets, Capsules, Injectables, Syrups & Suspensions, Topical Formulations, Inhalers); By Therapeutic Area (Oncology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Diseases, Diabetes, Others); By End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutes); By Trend Analysis, Competitive Landscape & Forecast, 2021-2032
The China Pharmaceutical Contract Manufacturing Market will experience substantial growth between 2026 and 2032 because of two factors which include domestic pharmaceutical and biotechnology industry expansion and increasing worldwide demand for affordable drug manufacturing. Multinational pharmaceutical companies increase their outsourcing activities while the demand for generic drugs and biologics and specialty medicines increases which drives contract manufacturing facility investments throughout China.
- Manufacturing
- Feb 2026
- Pages 200
- Report Format: pdf
- Report Price $2500 USD